Maintenance fees coming due
GlaxoSmithKline Biologicals S.A.
101 maintenance fees come due in the 12 months from Nov 18, 2026, the next on Dec 4, 2026. Unpaid by Jun 4, 2027, that one lapses early.
A maintenance fee does not end a patent on its due date. It falls due at 3.5, 7.5
and 11.5 years from grant, and the patent lapses only if the fee is still unpaid at the end of the
six month grace period that follows.
| Patent | Title | Holder | Status | Fee due | Lapses if unpaid | Expires | Confidence |
|---|---|---|---|---|---|---|---|
| US 10,307,374 | Oil-In-Water Emulsions That Contain Nucleic Acids In force Fee due Dec 4, 2026 Lapses if unpaid Jun 4, 2027 · High confidence | GlaxoSmithKline Biologicals S.A. | In force | Dec 4, 2026 | Jun 4, 2027 | High confidence | |
| US 10,307,473 | Capsular Gram-Positive Bacteria Bioconjugate Vaccines In force Fee due Dec 4, 2026 Lapses if unpaid Jun 4, 2027 · Medium confidence | GlaxoSmithKline Biologicals S.A. | In force | Dec 4, 2026 | Jun 4, 2027 | Medium confidence | |
| US 10,307,474 | Modified Host Cells and Hybrid Oligosaccharides for Use in Bioconjugate Production In force Fee due Dec 4, 2026 Lapses if unpaid Jun 4, 2027 · High confidence | GlaxoSmithKline Biologicals S.A. | In force | Dec 4, 2026 | Jun 4, 2027 | High confidence | |
| US 11,666,534 | Methods of Administering Lipid Formulations with Viral Immunogens In force Fee due Dec 6, 2026 Lapses if unpaid Jun 7, 2027 · Medium confidence | GlaxoSmithKline Biologicals S.A. | In force | Dec 6, 2026 | Jun 7, 2027 | Medium confidence | |
| US 9,057,716 | Bactericidal Antibody Assays to Assess Immunogenicity and Potency of Meningococcal Capsular Saccharide Vaccines In force Fee due Dec 16, 2026 Lapses if unpaid Jun 16, 2027 · High confidence | GlaxoSmithKline Biologicals S.A. | In force | Dec 16, 2026 | Jun 16, 2027 | High confidence | |
| US 11,679,149 | Immunogenic Compositions In force Fee due Dec 20, 2026 Lapses if unpaid Jun 21, 2027 · High confidence | GlaxoSmithKline Biologicals S.A. | In force | Dec 20, 2026 | Jun 21, 2027 | High confidence | |
| US 11,679,153 | Novel Methods for Inducing an Immune Response In force Fee due Dec 20, 2026 Lapses if unpaid Jun 21, 2027 · Medium confidence | GlaxoSmithKline Biologicals SA | In force | Dec 20, 2026 | Jun 21, 2027 | Medium confidence | |
| US 9,060,965 | Purification of Staphylococcus Aureus Type 5 Capsular Saccharides In force Fee due Dec 23, 2026 Lapses if unpaid Jun 23, 2027 · High confidence | GlaxoSmithKline Biologicals S.A. | In force | Dec 23, 2026 | Jun 23, 2027 | High confidence | |
| US 9,066,899 | Vaccines In force Fee due Dec 30, 2026 Lapses if unpaid Jun 30, 2027 · High confidence | GlaxoSmithKline Biologicals S.A. | In force | Dec 30, 2026 | Jun 30, 2027 | High confidence | |
| US 11,690,861 | Delivery of RNA to Trigger Multiple Immune Pathways In force Fee due Jan 4, 2027 Lapses if unpaid Jul 6, 2027 · Medium confidence | GlaxoSmithKline Biologicals S.A. | In force | Jan 4, 2027 | Jul 6, 2027 | Medium confidence | |
| 91 more maintenance fees coming due in the 12 months from Nov 18, 2026 · Pro | |||||||
10 of 101 patents shown. Soonest fee due date first, then patent number.
Pro members see every patent with a maintenance fee coming due: number, title, status, the due date, and the date it lapses if the fee goes unpaid through the grace period.
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.